Title: Antiparkinsonian action of a selective group III mGlu receptor agonist is associated with reversal of subthalamonigral overactivity.
Journal: Neurobiology of disease 20120401
Title: Therapeutic potential of targeting group III metabotropic glutamate receptors in the treatment of Parkinson's disease.
Journal: British journal of pharmacology 20100901
Title: A virtual screening hit reveals new possibilities for developing group III metabotropic glutamate receptor agonists.
Journal: Journal of medicinal chemistry 20100408
Title: Group III mGlu receptor agonist, ACPT-I, attenuates morphine-withdrawal symptoms after peripheral administration in mice.
Journal: Progress in neuro-psychopharmacology & biological psychiatry 20091113
Title: The group III mGlu receptor agonist ACPT-I exerts anxiolytic-like but not antidepressant-like effects, mediated by the serotonergic and GABA-ergic systems.
Journal: Neuropharmacology 20090901
Title: Peripheral administration of group III mGlu receptor agonist ACPT-I exerts potential antipsychotic effects in rodents.
Journal: Neuropharmacology 20080901
Title: Targeting group III metabotropic glutamate receptors produces complex behavioral effects in rodent models of Parkinson's disease.
Journal: The Journal of neuroscience : the official journal of the Society for Neuroscience 20070620
Title: The influence of group III metabotropic glutamate receptor stimulation by (1S,3R,4S)-1-aminocyclo-pentane-1,3,4-tricarboxylic acid on the parkinsonian-like akinesia and striatal proenkephalin and prodynorphin mRNA expression in rats.
Journal: Neuroscience 20070316
Title: Combined administration of PHCCC, a positive allosteric modulator of mGlu4 receptors and ACPT-I, mGlu III receptor agonist evokes antidepressant-like effects in rats.
Journal: Amino acids 20070201
Title: Design and synthesis of APTCs (aminopyrrolidinetricarboxylic acids): identification of a new group III metabotropic glutamate receptor selective agonist.
Journal: Bioorganic & medicinal chemistry letters 20060915
Title: Anxiolytic-like effects of group III mGlu receptor ligands in the hippocampus involve GABAA signaling.
Journal: Pharmacological reports : PR 20060101
Title: Anxiolytic action of group II and III metabotropic glutamate receptors agonists involves neuropeptide Y in the amygdala.
Journal: Pharmacological reports : PR 20050101
Title: Group III mGlu receptor agonists produce anxiolytic- and antidepressant-like effects after central administration in rats.
Journal: Neuropharmacology 20040201
Title: Common and selective molecular determinants involved in metabotopic glutamate receptor agonist activity.
Journal: Journal of medicinal chemistry 20020718
Title: Anxiolytic- and antidepressant-like effects of group III metabotropic glutamate agonist (1S,3R,4S)-1-aminocyclopentane-1,3,4-tricarboxylic acid (ACPT-I) in rats.
Journal: Polish journal of pharmacology 20020101
Title: Pharmacological characterization of the rat metabotropic glutamate receptor type 8a revealed strong similarities and slight differences with the type 4a receptor.
Journal: European journal of pharmacology 20000407
Title: Synthesis and pharmacological characterization of aminocyclopentanetricarboxylic acids: new tools to discriminate between metabotropic glutamate receptor subtypes.
Journal: Journal of medicinal chemistry 19970912
